Search

Reading Time: 3 minutes How will value-based healthcare be reflected in the pharma, medical and insurance industries?

Article

Reading Time: 2 minutes Isn’t it great when you get really good, helpful customer service?

Article

Reading Time: 4 minutes Nine months after the release of Apple’s ResearchKit, we take a look at if it’s being used and how well the apps are performing in clinical research.

Article

Reading Time: 3 minutes The adoption rate of adaptive clinical trial designs will increase dramatically in the coming years.

Article

Reading Time: 2 minutes Does Moore’s Law translate to older, regulated industries such as pharma?

Article

Reading Time: 2 minutes In Christian Stammel’s NYAS talk about wearable tech’s impact on the healthcare market, he gave an overview of the wearables market as well as his take on what’s coming next.

Article

Reading Time: 2 minutes If you think wearable devices are just another tech fad that will go the way of AskJeeves and 3D televisions, think again.

Article

Reading Time: 2 minutes Will technology and data overhaul the healthcare system through increases in home-based patient monitoring?

Article

Reading Time: 3 minutesMany sponsors and CROs use Medidata’s Rave, a modern solution for electronic data capture and management. But when was the last time you checked how your trial master file (TMF) is organized and managed? The Importance of the Trial Master File The trial master file makes sure that regulators can reconstruct the events of a […]

Article

Reading Time: 3 minutes The prospects of Big Data are tantalizing for the life sciences industry, but there’s still much left to do with small data.

Article

Reading Time: 2 minutes Part one of a two-part series about the perceived challenges of introducing tech in clinical research as well as the groundbreaking opportunities for tech in the field.

Article

Reading Time: 4 minutesThis blog was authored by Marc Kaufman, Senior Product Director, Product Management at Medidata. Planning, implementing, and managing technology are important considerations during the trial planning phase. Also essential is incorporating flexible randomization and trial supply management (RTSM) systems (sometimes referred to as interactive response technology, or IRT), as they can alter treatments and randomization […]

Article